$CWBHF
Stock $cwbhf

$cwbhf Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000175015523000083 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$15.85M	$14.29M
YoY Change	-16.02%	-16.1%
Cost Of Revenue	$7.043M	$6.365M
YoY Change	-76.07%	-21.34%
Gross Profit	$8.802M	$7.929M
YoY Change	-183.28%	-11.36%
Gross Profit Margin	55.55%	55.47%
Selling, General & Admin	$17.83M	$19.89M
YoY Change	-16.73%	80.28%
% of Gross Profit	202.59%	250.84%
Research & Development	$769.0K
YoY Change
% of Gross Profit	8.74%
Depreciation & Amortization	$3.650M	$3.740M
YoY Change	13.85%	105.27%
% of Gross Profit	41.47%	47.17%
Operating Expenses	$18.60M	$19.89M
YoY Change	-13.14%	80.28%
Operating Profit	-$9.799M	-$11.96M
YoY Change	-69.36%	205.96%
Interest Expense	$3.751M	-$4.020M
YoY Change	-204.78%	0.5%
% of Operating Profit
Other Income/Expense, Net	-$1.460M	$841.0K
YoY Change	-431.82%	161.99%
Pretax Income	-$8.056M	-$15.14M
YoY Change	-77.07%	99.57%
Income Tax	$529.0K	$0.00
% Of Pretax Income
Net Earnings	-$8.585M	-$15.14M
YoY Change	-75.63%	99.57%
Net Earnings / Revenue	-54.18%	-105.94%
Basic Earnings Per Share		-$0.10
Diluted Earnings Per Share	-$0.06	-$0.10
COMMON SHARES
Basic Shares Outstanding	153.8M shares	153.0M shares
Diluted Shares Outstanding		153.1M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.82M	$51.00M
YoY Change	-28.59%	208.85%
Cash & Equivalents	$47.82M	$51.02M
Short-Term Investments
Other Short-Term Assets	$6.864M	$7.600M
YoY Change	-14.18%	67.77%
Inventory	$21.54M	$22.63M
Prepaid Expenses	$2.813M
Receivables	$1.950M	$2.492M
Other Receivables	$379.0K	$0.00
Total Short-Term Assets	$78.17M	$83.74M
YoY Change	-24.66%	12.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.51M	$28.06M
YoY Change	-6.2%	-9.75%
Goodwill
YoY Change
Intangibles	$887.0K	$1.382M
YoY Change	-49.92%	-31.52%
Long-Term Investments	$11.00M	$11.10M
YoY Change
Other Assets	$703.0K	$1.389M
YoY Change	-87.82%	-76.91%
Total Long-Term Assets	$74.38M	$80.12M
YoY Change	-11.33%	20.78%
TOTAL ASSETS
Total Short-Term Assets	$78.17M	$83.74M
Total Long-Term Assets	$74.38M	$80.12M
Total Assets	$152.5M	$163.9M
YoY Change	-18.7%	16.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.860M	$3.577M
YoY Change	-28.82%	38.43%
Accrued Expenses	$8.682M	$7.221M
YoY Change	25.84%	-2.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$23.65M	$24.78M
YoY Change	10.36%	88.49%
LONG-TERM LIABILITIES
Long-Term Debt	$42.53M	$40.40M
YoY Change	13.63%	118.3%
Other Long-Term Liabilities	$30.82M	$35.00M
YoY Change	-39.91%	1749900.0%
Total Long-Term Liabilities	$73.34M	$75.40M
YoY Change	-17.32%	3769900.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.65M	$24.78M
Total Long-Term Liabilities	$73.34M	$75.40M
Total Liabilities	$96.99M	$100.1M
YoY Change	-11.94%	216.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$271.7M	-$263.1M
YoY Change	9.6%	23.71%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$55.56M	$63.74M
YoY Change
Total Liabilities & Shareholders Equity	$152.5M	$163.9M
YoY Change	-18.7%	16.62%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$8.585M	-$15.14M
YoY Change	-75.63%	99.57%
Depreciation, Depletion And Amortization	$3.650M	$3.740M
YoY Change	13.85%	105.27%
Cash From Operating Activities	-$2.536M	-$7.840M
YoY Change	-6.63%	-565.28%
INVESTING ACTIVITIES
Capital Expenditures	$671.0K	$2.830M
YoY Change	-559.59%	-3728.21%
Acquisitions
YoY Change
Other Investing Activities	$65.00K	$80.00K
YoY Change	-78.76%	-77.4%
Cash From Investing Activities	-$606.0K	-$2.750M
YoY Change	-234.07%	-1096.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-51.00K	-120.0K
YoY Change	-100.1%	-54.72%
NET CHANGE
Cash From Operating Activities	-2.536M	-7.840M
Cash From Investing Activities	-606.0K	-2.750M
Cash From Financing Activities	-51.00K	-120.0K
Net Change In Cash	-3.193M	-10.71M
YoY Change	-106.33%	-731.49%
FREE CASH FLOW
Cash From Operating Activities	-$2.536M	-$7.840M
Capital Expenditures	$671.0K	$2.830M
Free Cash Flow	-$3.207M	-$10.67M
YoY Change	24.79%	-705.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7221000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7344000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2249000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2306000	usd
CY2023Q3	cweb	License Payable Current LicensePayableCurrent	11734000	usd
CY2022Q4	cweb	License Payable Current LicensePayableCurrent	7759000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1822000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3909000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-30265000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20488000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	10700000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2023Q3	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	-4024000	usd
CY2022Q3	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	-4000000	usd
	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	5588000	usd
	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	-3900000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	841000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	321000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1234000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	304000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15143000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7588000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15211000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24084000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15143000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-7588000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15211000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-24084000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	77505000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	375000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2912000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	74899000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	624000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2844000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	78361000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	647000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15143000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	63738000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130446000	usd
CY2022Q1	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	165000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-2000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1214000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-8626000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	123152000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	643000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-7870000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	115912000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-59000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	664000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-7588000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	108862000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15211000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-24084000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11509000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5762000	usd
	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	5588000	usd
	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	-3900000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	10700000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2916000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1822000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1646000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2686000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1453000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1877000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1187000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-89000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	730000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1857000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1594000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-679000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1151000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2928000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3593000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-112000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	589000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3086000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-328000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4238000	usd
	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	1722000	usd
	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	1665000	usd
	cweb	Increase Decrease In License Payable IncreaseDecreaseInLicensePayable	6000000	usd
	cweb	Increase Decrease In License Payable IncreaseDecreaseInLicensePayable	0	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-4261000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6575000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	449000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2449000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12849000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2599000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3015000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	411000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	119000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	354000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2896000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-202000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-325000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-202000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-325000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15947000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2981000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66963000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19494000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51016000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16513000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	81000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0	usd
	us-gaap	Notes Issued1 NotesIssued1	142000	usd
	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14294000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17037000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47310000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55271000	usd
CY2023Q3	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	2332000	usd
CY2023Q3	us-gaap	Derivative Assets DerivativeAssets	778000	usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3110000	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	11100000	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	7407000	usd
CY2022Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	2300000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1320000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3620000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12995000	usd
CY2021Q1	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	usd
CY2021Q1	cweb	Business Combination Purchase Option Term BusinessCombinationPurchaseOptionTerm	P5Y
CY2021Q1	cweb	Business Combination Purchase Option Extension Term BusinessCombinationPurchaseOptionExtensionTerm	P2Y
CY2021Q1	cweb	Class Of Warrant Or Right Percentage Of Outstanding Shares ClassOfWarrantOrRightPercentageOfOutstandingShares	0.10
CY2021Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P60D
CY2023Q3	cweb	Gain Loss On Fair Value Adjustment Business Combination Purchase Option GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption	275000	usd
CY2022Q3	cweb	Gain Loss On Fair Value Adjustment Business Combination Purchase Option GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption	-4000000	usd
	cweb	Gain Loss On Fair Value Adjustment Business Combination Purchase Option GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption	32000	usd
	cweb	Gain Loss On Fair Value Adjustment Business Combination Purchase Option GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption	-3900000	usd
CY2023Q3	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	2332000	usd
CY2022Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	2300000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	19864000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	34763000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	9491000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10960000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7725000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13237000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	37080000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	58960000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	14449000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	32007000	usd
CY2023Q3	cweb	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	22631000	usd
CY2022Q4	cweb	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	26953000	usd
	cweb	Inventory Provision Period Increase Decrease InventoryProvisionPeriodIncreaseDecrease	-12854000	usd
CY2023Q3	cweb	Licensed Properties LicensedProperties	16412000	usd
CY2022Q4	cweb	Licensed Properties LicensedProperties	23399000	usd
CY2023Q3	cweb	Media Rights MediaRights	6107000	usd
CY2022Q4	cweb	Media Rights MediaRights	7482000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	884000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3201000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2892000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2169000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1844000	usd
CY2023Q3	cweb	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	13647000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	24637000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6148000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	18489000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2249000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16240000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1822000	usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1822000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15143000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-7588000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15211000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-24084000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	153094229	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145334992	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152632806	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145203515	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153094229	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145334992	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152632806	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145203515	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10095176	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10095176	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7468731	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7468731	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.888
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.858
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.034
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.033
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q3	us-gaap	Share Price SharePrice	0.36
CY2022Q3	us-gaap	Share Price SharePrice	0.43
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3957027	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.52
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M13D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	46800	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3748671	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.38
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1170291	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.38
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6535407	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M3D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	90010	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2745812	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.17
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y5M26D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.38
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.11
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	0
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1150000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	881000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2569574	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.98
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3598076	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.27
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	436785	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.22
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1644830	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.70
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriod	526266	shares
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriodWeightedAverageGrantDateFairValue	0.77
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3559769	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.39
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	647000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	664000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1646000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2686000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3347000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	4106000	usd
CY2023Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	4261000	usd
CY2023Q3	cweb	Interest Income On Income Tax Refund Amount InterestIncomeOnIncomeTaxRefundAmount	155000	usd
CY2020Q4	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.0325
CY2021Q1	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	usd
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001750155-23-000083-index-headers.html	Edgar Link	pending
0001750155-23-000083-index.html	Edgar Link	pending
0001750155-23-000083.txt	Edgar Link	pending
0001750155-23-000083-xbrl.zip	Edgar Link	pending
cweb-20230930.htm	Edgar Link	pending
cweb-20230930.xsd	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
cweb-20230930_cal.xml	Edgar Link	unprocessable
cweb-20230930_def.xml	Edgar Link	unprocessable
cweb-20230930_lab.xml	Edgar Link	unprocessable
cweb-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cweb-20230930_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBHF
Stock $cwbhf

2023 Q4 Form 10-Q Financial Statement

#000175015523000083 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF Stock $cwbhf

2023 Q4 Form 10-Q Financial Statement

#000175015523000083 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF
Stock $cwbhf